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Acute Acalculous Cholecystitis-Associated
Bacteremia Has Worse Outcome
Javier E. Rincon, Rohit K. Rasane, Jose A. Aldana, Christina X. Zhang, Ricardo A. Fonseca,
Qiao Zhang, Kelly M. Bochicchio, Obeid N. Ilahi, and Grant V. Bochicchio

Abstract

Background: Acute acalculous cholecystitis (AAC) is an inflammation of the gallbladder without gallstones in
the setting of critical illness. It represents 2%–15% of acute cholecystitis (AC) cases. Bacteremia is associated
with increased morbidity and mortality rates in patients in the intensive care unit (ICU). The incidence of
bacteremia in acute calculous cholecystitis (ACC) has been described; however, the incidence of bacteremia in
AAC has not been reported. We hypothesized that patients with AAC have higher bacteremia rates, leading to
worse outcomes than in those with ACC.
Methods: A prospectively collected acute care surgery (ACS) institutional database of patients treated from
2008 through 2018 was queried for patients having ACC using International Classification of Diseases (ICD) 9
and 10 codes. Demographics, microbiology findings, and outcomes were extracted. Only patients with positive
blood cultures were included in the study. We defined two cohorts: AAC with bacteremia and ACC with
bacteremia. The Student t-test was used for continuous variables and the w2 and Fisher exact tests for categorical
variables. Multivariable regression was applied, and statistical significance was set at p < 0.05.
Results: Of 323 patients with AC, 57 (17.6%) had AAC and 266 (82.4%) had ACC. Of the 19 patients who had
a blood culture, 11 (57.8%) were positive. Patients with positive blood cultures had a mean age of 56.7 – 15.3
years and a mean Body Mass Index (BMI) of 26.7 – 4.9. The incidence of bacteremia was significantly higher in
AAC (n = 6; 10.5% versus n = 5; 1.9 %; p = 0.005), although the time between admission and diagnosis of
bacteremia was similar in the two groups (1.2 – 1.1 versus 0.2 – 0.5 days; p = 0.128). The patients with AAC and
bacteremia were younger (53.8 – 19.2 versus 60.2 – 8 years; p = 0.021) and had a longer ICU length of stay
(LOS) (12.6 – 7.2 versus 1.3 – 2.1 days; p = 0.030). However, there was no difference in the mortality rate in the
groups (n = 2; 33.3% versus 1; 20.0%; p = 1.000). After adjusting for age, gender, BMI, and Charlson Comorbidity Index, bacteremia in AAC patients was found to be an independent variable for longer ICU LOS
(odds ratio 8.8; 95% confidence interval 1.7–15.9; p = 0.024).
Conclusions: The incidence of bacteremia in patients with AAC is five-fold higher and the ICU stay eight days
longer than in patients with ACC.
Keywords: acalculous cholecystitis; bacteremia; calculous cholecystitis

A

cute cholecystitis (AC) is defined as a sudden-onset
inflammation of the gallbladder (GB) that causes severe
right upper quadrant pain. This condition is responsible for
approximately 3%–10% of all cases of abdominal pain [1].
According to the presence or absence of gallstones, this
disease can be classified as acute calculous cholecystitis
(ACC), which accounts for 90% of all cases of AC, and acute
acalculous cholecystitis (AAC) [2]. The latter is an inflammatory condition of the GB wall in the absence of choleli-

thiasis, sludge, or cystic duct obstruction on diagnostic
imaging and represents 2%–15% of total AC cases [3,4].
Although it is not well understood, the pathogenesis of AAC
most likely is related to GB wall stasis, ischemia, and necrosis [5]. The acalculous condition commonly occurs in
critically ill patients with multifactorial risk factors, such as
major trauma, non-biliary operations, total parenteral nutrition (TPN) use, sepsis, acquired immunodeficiency syndrome, diabetes, malignant tumors, and bone marrow
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transplantation [6–10]. Predisposing risk factors and use of
invasive medical devices in the ICU setting increase the
likelihood of bacteremia, which in turn is well known to
increase morbidity and death [11]. The incidence of bacteremia in ACC has been described [12,13]; however, the incidence of bacteremia in AAC is not established. We
hypothesized that patients with AAC have higher bacteremia
rates and worse outcomes than patients with ACC.
Patients and Methods

A prospectively collected acute care surgery (ACS) institutional database from 2008 through 2018 was queried for
patients having AC using the following International Classification of Diseases (ICD) codes: 9 (574x, 574.1x, 574.3x,
574.4x, 574.6x, 574.7x, 575x, 575.1x) and 10 (K80.00x,
K80.01x, K80.18x, K80.19x, K80.40x, K80.41x, K80.42x,
K80.43x, K80.60x, K80.61x, K80.62x, K80.63x, K81.0x,
K81.9x, K82.A1x, K82.A2x). A total of 323 patients were
found to have AC. All these patients had undergone cholecystectomy (laparoscopic or open surgery). The diagnosis of
AAC was based on abdominal ultrasonography and intraoperative findings of the absence of stones or sludge in the
GB. Also, surgical pathology reports confirmed the diagnosis
of AAC in the absence of biliary calculi along with the acute
inflammatory characteristics. Microbiology data including
blood cultures were abstracted to identify the species, genus,
and resistance markers in blood stream infections before
initiating antibiotics using the Verigene gram-positive and
gram-negative blood culture nucleic acid tests. Acquired
bacteremia associated with AC was defined as a positive
culture of a sample drawn in the ICU after the diagnosis of
AC was established. Therefore, only patients with positive
blood cultures were included in the study.
On the basis of the cultures, we established two cohorts:
AAC with bacteremia and ACC with bacteremia. All the
patients were started on empiric antibiotics after blood cultures were obtained. In order to have homogenous cohorts in
terms of source control, we excluded patients who underwent
percutaneous cholecystostomy (PC), as well as patients who
were younger than 18 years, who had incomplete data without blood culture results, or those with negative blood cultures and with chronic cholecystitis. Demographic data such
as age, gender, and Body Mass Index (BMI) were abstracted.
We evaluated the following hospital outcomes: Length of
stay (LOS), ICU LOS, and death. The Student t-test was used
for continuous variables and the w2 and Fisher exact tests for
categorical variables. Significant outcome differences between the two groups (AAC with bacteremia and ACC with
bacteremia) were seen on univariable analysis, and linear
regression was applied as appropriate. Statistical significance
was set at p < 0.05. Statistical Package for the Social Sciences
version 23.0 was used for data analysis.

Results

Of the total 323 patients with AC who underwent cholecystectomy, 57 (17.6%) had AAC and 266 (82.4%) had ACC.
Of the 19 patients (5.9%) who had a blood culture performed,
11 (57.8%) were positive and were included in the study. The
blood culture testing was done on average 3 days –3 days
after the diagnosis of AC was made.
The incidence of bacteremia was significantly higher in
AAC (n = 6; 10.5% versus n = 5; 1.9 %; p = 0.005) than the
ACC group, as described in Table 1. Of the 11 patients included in the study, 7 (63.6 %) were male (n = 4; 66.7%
versus n = 3; 60.0%; p = 1.000), indicating a male predominance in both groups with a somewhat higher predominance
in the AAC cohort. The mean age of the total series was
56.7 – 15.3 years; of these, the patients in the AAC group
were significantly younger (53.8 – 19.2 versus 60.2 – 8 years;
p = 0.021). The mean BMI of the total cohort was 26.7 – 4.9,
and no significant difference was found between the groups.
The time of diagnosis of bacteremia from admission was
similar in both groups (1.2 – 1.1 versus 0.2 – 0.5 days;
p = 0.128). No significant differences were found in the
Charlson Comorbidity Index (4.7 – 3.1 versus 4.6 – 2;
p = 0.791) or the Acute Physiology, Age, and Chronic Health
Evaluation (APACHE) II score (17.8 – 5.8 versus 11.8 – 4.3;
p = 0.089). The source control was either open or laparoscopic cholecystectomy; no significant difference was found
in the time between AAC and ACC diagnosis and source
control (2.2 – 3.9 versus 5.6 – 2.7 hours; p = 0.130). The demographic data are listed in Table 2.
In unadjusted univariable analysis for hospital outcomes
(Table 3), there was no difference in LOS between the groups
(22.3 – 3.7 versus 15.7 – 12.6 days; p = 0.961). However, the
AAC patients had a significantly longer ICU LOS (12.6 – 7.2
versus 1.3 – 2.1 days; p = 0.030). There was no difference in
the mortality rate in the two cohorts (n = 2; 33.3% versus 1;
20.0%; p = 1.000). There were no correlations between the
type of source control (open vs. laparoscopic cholecystectomy) and death (n = 3; 42.9% versus 0; p = 0.212) or between
the time to source control and death (5.0 – 4.6 versus
3.25 – 1.3 days; p = 0.513).
We performed linear regression analysis to adjust for potential confounding factors using ICU LOS as the outcome.
In this model, after adjusting for age, gender, BMI, and
Charlson Comorbidity Index, bacteremia in AAC patients
was found to be an independent variable for longer ICU LOS
(odds ratio [OR] 8.8; 95% confidence interval [CI]
1.7–15.9 days; p = 0.024) as seen in Table 4.
The micro-organisms isolated from blood cultures of AAC
patients were Staphylococcus spp., Streptococcus spp., Enterococcus spp., E. coli, Candida spp., and mold. In the ACC
group, the micro-organisms were Staphylococcus spp., Propionibacterium spp., Corynebacterium spp., Enterococcus

Table 1. Incidence of Bacteremia in Patients with Acute Acalculous (AAC)
and Acute Calculus (ACC) Cholecytitis
Characteristics
Blood culture (+)
Blood culture (-)

Total n = 323 (%)

AAC (n = 57; 17.6%)

ACC (n = 266; 82.4%)

p

11 (03.40)
312 (96.6)

6 (10.5)
51 (89.5)

5 (01.9)
261 (98.1)

0.005

Statistically significant differences are shown in bold.
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Table 2. Univariable Analysis of Demographic Data by Diagnosis in Patients with Positive Blood Cultures
Characteristic

Total n = 11

AAC (n = 6; 10.5%)

ACC (n = 5; 1.87%)

p

Age – SD
Gender
Male (%)
Female (%)
BMI – SD
CCI – SD
APACHE II Score – SD
Bacteremia diagnosis time from admission (d)
AC diagnosis to source control (d)

56.7 (– 15.3)

53.8 (– 19.2)

60.2 (– 8.1)

0.021
1.000

7 (63.6)
4 (36.4)
26.7 – 4.9
4.6 – 2.8
15.1 – 5.9
0.7 – 0.9
3.7 – 3.7

4 (66.7)
2 (33.3)
26.8 – 3.9
4.7 – 3.1
17.8 – 5.8
1.2 – 1.1
2.2 – 3.9

3 (60.0)
2 (40.0)
26.7 – 6.6
4.6 – 2.6
11.8 – 4.3
0.2 – 0.5
5.6 – 2.7

0.074
0.791
0.089
0.128
0.130

Statistically significant differences are shown in bold.
AAC = acute acalculous cholecystitis; AC = acute cholecystitis; ACC = acute calculous cholecystitis; APACHE = Acute Physiology, Age,
and Chronic Health Evaluation; CCI = Charlson Comorbidity Index; SD = standard deviation.

Table 3. Univariable Analysis of Hospital Outcomes (Intensive Care Unit [ICU] Length of Stay [LOS] [d])
in Patients with Acute Acalculous Cholecystitis (AAC) or Acute Calculous Cholecystitis (ACC)
and Positive Blood Culture
Hospital outcome

Total n = 11

AAC (n = 6; 10.5%)

ACC (n = 5; 1.9%)

p

LOS
ICU LOS
Death (%)

19.3 (– 13.0)
7.5 (– 7.9)
3 (27.3)

22.3 (– 3.7)
12.6 (– 7.2)
2 (33.3)

15.7 (– 12.6)
1.3 (– 2.1)
1 (20)

0.961
0.030
1.000

Statistically significant differences are shown in bold.
ICU = intensive care unit; LOS = length of stay.

spp., Klebsiella spp., Enterobacter spp., and Candida
spp. The most common pathogen in both groups was Staphylococcus (AAC [n = 2; 28.5 %] and AAC [n = 2; 25.0%]).
No significant differences were found in the distribution of
the micro-organisms (Tables 5 and 6).
Discussion

Acute acalculous cholecystitis remains difficult to diagnose, likely because of the complicated clinical environments
in which this disease develops. Notably, AAC is present in
0.2% to 0.4% of all critically ill patients [14], with predisposing multi-factorial risk factors including surgery, trauma,
shock, burns, sepsis, and TPN use [6–10]. In our study, the
suspected underlying cause of AAC was sepsis.
Percutaneous cholecystostomy is most commonly indicated in critically ill patients with AC with serious comorbidities who are at risk from major surgery or when there
is no response to antibiotics, especially in patients with AAC.

Table 4. Linear Regression to Adjust
for Confounding Factors Affecting Length
of Stay in Intensive Care Unit
Variables
AAC vs. ACC
Age
Gender
BMI
Charlson
Comorbidity
Index

Coefficient
8.83
-0.42
5.73
0.31
1.61

95% CI
1.71–
-0.78–
-3.14–
-0.48–
-0.39–

15.94
-0.05
14.62
01.12
03.27

However, we included only patients with AC who were
managed surgically (open or laparoscopy cholecystectomy)
in order to have homogeneous cohorts in terms of source
control. Similarly, Ganpathi et al. in 2007 [3] analyzed 133
patients with AC who had cholecystectomy (laparoscopic or
open surgery), and they observed the de novo presentation of
AAC in several of their patients.
Studies from Ganpathi et al. [3] and Kalliafas et al. in 1998
[15] demonstrated that the incidence of AAC ranges from
10%–14%. In our study population, the incidence of AAC
was 17.6%, slightly higher than in these earlier reports.
Previous studies have shown the impact and epidemiology
of bacteremia on outcomes for patients admitted to the ICU
and also revealed that bacteremia is one of the major causes
of morbidity and death in the ICU [11,16,17]. These studies
further emphasized the importance of early diagnosis of
bacteremia in critically ill patients along with the rapid initiation of antibiotics to improve clinical outcomes. The incidence of bacteremia has increased over time despite the
availability of appropriate antibiotic therapy [18].

Table 5. Microorganisms Isolated from Patients
with Acute Acalculous Cholecystitis
p

0.024
0.031
0.151
0.361
3.271

Statistically significant differences are shown in bold.
AAC = acute acalculous cholecystitis; ACC = acute calculous
cholecystitis; BMI = Body Mass Index; CI = confidence interval.

Microorganism
Gram-positive organisms
Staphylococcus spp.
Streptococcus spp.
Enterococcus spp.
Gram-negative organism
E. coli
Fungus
Candida spp.
Other

N (%)
2 (28.5)
1 (14.3)
1 (14.3)
1 (14.3)
1 (14.3)
1 (14.3)
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Microorganism
Gram-positive organisms
Staphylococcus spp.
Propionibacterium spp.
Corynebacterium spp.
Enterococcus spp.
Gram-negative organisms
Klebsiella spp.
Enterobacter spp.
Fungus
Candida spp.

N (%)
2
1
1
1

(25.0)
(12.5)
(12.5)
(12.5)

1 (12.5)
1 (12.5)
1 (12.5)

Blood cultures are the gold standard for the diagnosis of
bacteremia. In a study done by Baitello et al. [12], the Bactec
system was used to detect bacteremia in patients with ACC.
In our institution, we used the Verigene nucleic acid tests to
diagnose gram-positive and gram-negative bacteremia in
patients with either AAC or ACC. The Verigene test is an
automated and rapid diagnostic method that identifies the
genus, species, and resistance patterns for a common set of
gram- negative and gram-positive bacteria within approximately 2.5 hours of the gram stain, with high sensitivity and
specificity [19–21].
Kuo et al. in 1995 [13] and Baitello et al. in 2004 [12]
described the impact of bacteremia in patients with ACC, in
which they observed the association of bacteremia with
greater severity of complications and worse hospital outcomes such as longer LOS and higher mortality rates.
However, these studies did not compare the outcomes of an
AAC cohort. We found significantly higher rates of positive
blood cultures in the patients with AAC, with the incidence of
bacteremia being five times that in the ACC group. This is a
unique finding that, to our knowledge, has not been described
previously.
Kuo et al. [13] also observed that the most common organisms found in ACC-associated bacteremia were gramnegative Enterobacteriaceae such as E. coli and Klebsiella
pneumoniae. Nevertheless, we found the most common microorganism grown from blood cultures in both groups to be
Staphylococcus.
Antimicrobial susceptibility testing of bacterial isolates
found high sensitivity to the antibiotics tested and guided the
treatment for our patients, mostly as a monotherapy regimen.
All the patients were started on empiric antibiotics after the
blood culture was collected. Thus, antibiotic use did not influence the incidence of bacteremia. Vancomycin was the
most common antibiotic used for gram-positive bacteria,
followed by linezolid, piperacillin-tazobactam, and meropenem for gram-negative bacteria.
According to Laurila et al. [20], critically ill patients who
developed AAC and underwent open cholecystectomy had
longer ICU LOS (19 days) and a higher mortality rate.
However, AAC was not associated with bacteremia. In contrast to the previous studies, we found that patients with AAC
with bacteremia stayed in the ICU eight days longer than
patients with ACC, which has not been described previously.
Even though the mortality rate was high in both AAC (33%)
and ACC (20%), no significant difference was found between

the two cohorts. This study also noted that the time from
admission to diagnosis of bacteremia was similar in the two
cohorts, which demonstrates that there was no delay in diagnosis of bacteremia in our institution that could have
caused the longer ICU LOS.
In the past, it has been seen that patients with AAC are
more acutely ill than those with ACC because of various comorbidities and risk factors [6–10]. However, in our patients,
no significant difference was found in the Charlson Comorbidity Index to support this previous result.
Although our study shows significant results, we were
limited by the fact that it was a retrospective study confined to
a single center. Another notable limitation was that a relatively small number of patients underwent blood cultures.
Therefore, these findings should be analyzed prospectively to
confirm the incidence data.
Conclusion

The incidence of bacteremia in patients with AAC was five
times that in patients with ACC. The former group of patients
stayed eight days longer in the ICU than those with ACC and
bacteremia. Although the mortality rate was high in both
AAC (33%) and ACC (20%) patients, there was no significant difference between the two groups. Further investigation
to identify these high-risk patients earlier is warranted.
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